Marta Tornese
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Marta Tornese has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Elena Trombetta
Flow Cytometry Laboratory, Clinical Pathology, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy
2 shared publications Alessandra Cattaneo
Flow Cytometry Laboratory, Clinical Pathology, Fondazione IRCCS ca' Granda Ospedale Maggiore Policlinico Milan Italy
1 shared publication- Anna Paola Marcello
Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico Milan Italy
1 shared publication - Anna Zaninoni
SC Ematologia, SS Fisiopatologia delle Anemie, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Via Francesco Sforza, 35, 20122 Milan, Italy
1 shared publication - Bruno Fattizzo
Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
1 shared publication - Cristina Vercellati
SC Ematologia, SS Fisiopatologia delle Anemie, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Via Francesco Sforza, 35, 20122 Milan, Italy
1 shared publication
Latest Publications
- Open Access
- 26 October 2025
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 102 (5) , e70062
Age‐Matched Reference Values for Circulating Natural Killer T ( NKT )‐Like Cells
Natural Killer T‐like cells are T lymphocytes characterised by the expression of CD56 accompanied by perforin and granzyme B production, typical of cytotoxic cells and the innate immunity compartment. Imbalance in their distribution could occur in pathological conditions, including solid or haematological cancers, autoimmune disorders and metabolic diseases; therefore we aimed to define age‐matched reference values of the NKT‐like population. NKT‐like cell count and their expression of CD4 and CD8 surface antigens were evaluated in 2208 subjects by flow cytometry, with a lyse‐no‐wash protocol in a CE‐IVD workup. Outpatients without alteration of any laboratory test and adult healthy volunteers were used to determine NKT‐like age‐matched reference values; a total of 490 subjects divided into six age ranges were finally enrolled. We defined reference values for NKT‐like cells in adult and in 5 age‐matched paediatric control groups. NKT‐like cell number increases with age both in percentage and absolute count. While NKT‐like/CD8+ cells increased with age, NKT‐like/CD4+ cells showed an opposite trend. Similarly, double‐positive cells (NKT‐like/CD4+ CD8+) gradually decreased with age, while double‐negative cells (NKT‐like/CD4‐CD8‐) increased up to 16 years and then decreased in adults. Ultimately, we evaluate adult and paediatric patients with NKT‐like cell count outside normal ranges derived here to highlight the principal associated conditions that may be involved. Our paper is a first step toward the definition of robust reference values for NKT‐like cell subpopulations under the CE‐IVD conditions. Providing NKT‐like cell number and frequency in the diagnostic report appears helpful to better delineate the immune profile of patients.
- 26 October 2025
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 102 (5) , e70062
Open AccessAge‐Matched Reference Values for Circulating Natural Killer T ( NKT )‐Like Cells
Natural Killer T‐like cells are T lymphocytes characterised by the expression of CD56 accompanied by perforin and granzyme B production, typical of cytotoxic cells and the innate immunity compartment. Imbalance in their distribution could occur in pathological conditions, including solid or haematological cancers, autoimmune disorders and metabolic diseases; therefore we aimed to define age‐matched reference values of the NKT‐like population. NKT‐like cell count and their expression of CD4 and CD8 surface antigens were evaluated in 2208 subjects by flow cytometry, with a lyse‐no‐wash protocol in a CE‐IVD workup. Outpatients without alteration of any laboratory test and adult healthy volunteers were used to determine NKT‐like age‐matched reference values; a total of 490 subjects divided into six age ranges were finally enrolled. We defined reference values for NKT‐like cells in adult and in 5 age‐matched paediatric control groups. NKT‐like cell number increases with age both in percentage and absolute count. While NKT‐like/CD8+ cells increased with age, NKT‐like/CD4+ cells showed an opposite trend. Similarly, double‐positive cells (NKT‐like/CD4+ CD8+) gradually decreased with age, while double‐negative cells (NKT‐like/CD4‐CD8‐) increased up to 16 years and then decreased in adults. Ultimately, we evaluate adult and paediatric patients with NKT‐like cell count outside normal ranges derived here to highlight the principal associated conditions that may be involved. Our paper is a first step toward the definition of robust reference values for NKT‐like cell subpopulations under the CE‐IVD conditions. Providing NKT‐like cell number and frequency in the diagnostic report appears helpful to better delineate the immune profile of patients.
- Open Access
- 10 August 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (16) , 7722
Not-So-Rare Defects of RBC Lipidic Composition: Four New Cases of Flippase Deficiency Due to ATP11C Mutations
Adenosine Triphosphatase (ATPase) Phospholipid Transporting 11C gene (ATP11C), located on the X chromosome, encodes the major phosphatidylserine flippase in human erythroid cells. Only five patients have so far been reported with defective ATP11C, displaying mild hemolytic anemia and reduced flippase activity. In this study, we report four Italian male patients in three unrelated families with novel private mutations in the ATP11C gene, resulting in impaired flippase activity associated with mild/compensated hemolytic anemia. The decreased flippase activity was measured as % of phosphatidylserine internalization over time and ranged after 20 min incubation from 5% to 18.6% in all patients, regardless of the type of molecular defect. Flippase activity was also tested in healthy controls, ranging from 43% to 62% in both males and females. This measurement appears to be a useful tool for hypothesizing ATP11C abnormalities in male subjects with mild compensated hemolysis, prior to next generation sequencing (NGS) analysis. Although rare, ATP11C mutations may be underrecognized, and therefore should be suspected and investigated in male patients presenting with subtle hemolytic signs or symptoms.
- 10 August 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (16) , 7722
Open AccessNot-So-Rare Defects of RBC Lipidic Composition: Four New Cases of Flippase Deficiency Due to ATP11C Mutations
Adenosine Triphosphatase (ATPase) Phospholipid Transporting 11C gene (ATP11C), located on the X chromosome, encodes the major phosphatidylserine flippase in human erythroid cells. Only five patients have so far been reported with defective ATP11C, displaying mild hemolytic anemia and reduced flippase activity. In this study, we report four Italian male patients in three unrelated families with novel private mutations in the ATP11C gene, resulting in impaired flippase activity associated with mild/compensated hemolytic anemia. The decreased flippase activity was measured as % of phosphatidylserine internalization over time and ranged after 20 min incubation from 5% to 18.6% in all patients, regardless of the type of molecular defect. Flippase activity was also tested in healthy controls, ranging from 43% to 62% in both males and females. This measurement appears to be a useful tool for hypothesizing ATP11C abnormalities in male subjects with mild compensated hemolysis, prior to next generation sequencing (NGS) analysis. Although rare, ATP11C mutations may be underrecognized, and therefore should be suspected and investigated in male patients presenting with subtle hemolytic signs or symptoms.